目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Strong Pipeline of Oligonucleotide Therapeutics in Clinical Trials
3.2.1.2. Changing Regulatory Environments For Genetic Research And Its Applications In Healthcare
3.2.1.3. High R & D Spending of Pharmaceutical - Biotechnology Companies
3.2.1.4. Increased Public-Private Spending on Genomics
3.2.1.5. Technological Advancements in Gene Editing Technologies
3.2.2. Market Restraint Analysis
3.2.2.1. Need For Advanced Oligo Synthesis Solutions
3.2.2.2. High Cost Associated with Genomics Research
3.2.2.3. Lack Of Skilled Professionals And Research Support In Undeveloped Countries
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis
4.1. Oligonucleotide Synthesis Market: Product Movement Analysis
4.2. Oligonucleotides
4.2.1. Oligonucleotides Market, 2018 - 2030 (USD Million)
4.2.2. Oligonucleotides, By Product Type
4.2.2.1 Column-Based Oligos
4.2.2.1.1 Global Column-Based Oligos Market, 2018 - 2030 (USD Million)
4.2.2.2 Array-Based Oligos
4.2.2.2.1 Global Array-Based Oligos Market, 2018 - 2030 (USD Million)
4.2.3. Oligonucleotides, By Nucleic Acid Type
4.2.3.1 DNA Oligos
4.2.3.1.1 Global DNA Oligo Market, 2018 - 2030 (USD Million)
4.2.3.2 RNA Oligos
4.2.3.2.1 Global RNA Oligo Market, 2018 - 2030 (USD Million)
4.3. Equipment/ Synthesizers
4.3.1. Global Oligonucleotide Synthesis Equipment Market, 2018 - 2030 (USD Million)
4.4. Reagents
4.4.1. Global Oligonucleotide Synthesis Reagents Market, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Global Oligonucleotide Services Market, 2018 - 2030 (USD Million)
4.5.2. Oligo Synthesis
4.5.2.1. Global Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.2. 25 nmol
4.5.2.2.1. Global 25 Nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.3. 50 nmol
4.5.2.3.1. Global 50 Nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.4. 200 nmol
4.5.2.4.1. Global 200 Nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.5. 1,000 nmol
4.5.2.5.1. Global 1,000 nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.6. 10,000 nmol
4.5.2.6.1. Global 10,000 nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.3. Purification
4.5.3.1. Global Oligonucleotide Purification Services Market, 2018 - 2030 (USD Million)
4.5.4. Modification
4.5.4.1. Global Oligonucleotide Modification Services Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis
5.1. Oligonucleotide Synthesis Market: Application Movement Analysis
5.2. PCR Primers
5.2.1. PCR Primers Market, 2018 - 2030 (USD Million)
5.3. PCR Assays and Panels
5.3.1. PCR Assays and Panels Market, 2018 - 2030 (USD Million)
5.4. Sequencing
5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
5.5. DNA Microarrays
5.5.1. DNA Microarrays Market, 2018 - 2030 (USD Million)
5.6. Fluorescence In Situ Hybridization (FISH)
5.6.1. Fluorescence In Situ Hybridization (FISH) Market, 2018 - 2030 (USD Million)
5.7. Antisense Oligonucleotides
5.7.1. Antisense Oligonucleotides Market, 2018 - 2030 (USD Million)
5.8. Other Applications
5.8.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6. End-User Business Analysis
6.1. Oligonucleotide Synthesis Market: End-User Movement Analysis
6.2. Academic and Research Institutes
6.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
6.3. Pharmaceutical & Biotechnology Companies
6.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.4. Diagnostic Laboratories
6.4.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis
7.1. Oligonucleotide Synthesis Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory Framework
7.2.3.3. Competitive Scenario
7.2.3.4. U.S. Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Regulatory Framework
7.2.4.3. Competitive Scenario
7.2.4.4. Canada Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory Framework
7.3.3.3. Competitive Scenario
7.3.3.4. UK Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory Framework
7.3.4.3. Competitive Scenario
7.3.4.4. Germany Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory Framework
7.3.5.3. Competitive Scenario
7.3.5.4. France Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory Framework
7.3.6.3. Competitive Scenario
7.3.6.4. Italy Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory Framework
7.3.7.3. Competitive Scenario
7.3.7.4. Spain Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory Framework
7.3.8.3. Competitive Scenario
7.3.8.4. Denmark Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory Framework
7.3.9.3. Competitive Scenario
7.3.9.4. Sweden Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Regulatory Framework
7.3.10.3. Competitive Scenario
7.3.10.4. Norway Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Scenario
7.4.3.4. Japan Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Scenario
7.4.4.4. China Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory Framework
7.4.5.3. Competitive Scenario
7.4.5.4. India Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory Framework
7.4.6.3. Competitive Scenario
7.4.6.4. Australia Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory Framework
7.4.7.3. Competitive Scenario
7.4.7.4. Thailand Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Regulatory Framework
7.4.8.3. Competitive Scenario
7.4.8.4. South Korea Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Scenario
7.5.3.4. Brazil Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework
7.5.4.3. Competitive Scenario
7.5.4.4. Mexico Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework
7.5.5.3. Competitive Scenario
7.5.5.4. Argentina Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Scenario
7.6.3.4. South Africa Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Scenario
7.6.4.4. Saudi Arabia Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Scenario
7.6.5.4. UAE Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework
7.6.6.3. Competitive Scenario
7.6.6.4. Kuwait Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck & Co. Inc
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PerkinElmer Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Agilent Technologies, Inc
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-synthesis, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Kaneka Eurogentec S.A
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Integrated DNA Technologies, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. BioAutomation (BIOSEARCH TECHNOLOGIES)
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Biolegio
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Twist Bioscience
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives

List of Tables
Table 1 List of abbreviations
Table 2 Global oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 3 Global oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 4 Global oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 5 Global oligonucleotide synthesis market, by region, 2018 - 2030 (USD Million)
Table 6 North America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 7 North America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 8 North America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 9 North America oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 10 U.S. oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. oligonucleotide synthesis Market, by end user, 2018 - 2030 (USD Million)
Table 13 Canada oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 14 Canada oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 15 Canada oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 16 Europe oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 17 Europe oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 18 Europe oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 19 Europe oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 20 UK oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 21 UK oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 22 UK oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 23 Germany oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 24 Germany oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 25 Germany oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 26 France oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 27 France oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 28 France oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 29 Italy oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 30 Italy oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 31 Italy oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 32 Spain oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 33 Spain oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 34 Spain oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 35 Denmark oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 37 Denmark oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 38 Sweden oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 40 Sweden oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 41 Norway oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 42 Norway oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 43 Norway oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 44 Asia Pacific oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 48 Japan oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 49 Japan oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 50 Japan oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 51 China oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 52 China oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 53 China oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 54 India oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 55 India oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 56 India oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 57 Australia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 58 Australia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 59 Australia oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 60 Thailand oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 62 Thailand oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 63 South Korea oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 65 South Korea oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 66 Latin America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 69 Latin America oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 70 Brazil oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 72 Brazil oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 73 Mexico oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 74 Mexico oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 75 Mexico oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 76 Argentina oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 83 South Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 89 UAE oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 90 UAE oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 91 UAE oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 92 Kuwait oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)

List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 Market formulation & validation
FIG. 7 single-cell omics market segmentation
FIG. 8 Market snapshot, 2022
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Market restraint relevance analysis (current & future impact)
FIG. 12 PESTEL analysis
FIG. 13 Porter’s five forces analysis
FIG. 14 Global oligonucleotide synthesis market: Product movement analysis
FIG. 15 Global oligonucleotide synthesis market, for oligonucleotides, 2018 - 2030 (USD Million)
FIG. 16 Global column-based oligos market, 2018 - 2030 (USD Million)
FIG. 17 Global array-based oligos market, 2018 - 2030 (USD Million)
FIG. 18 Global DNA oligonucleotides market, 2018 - 2030 (USD Million)
FIG. 19 Global RNA oligonucleotides market, 2018 - 2030 (USD Million)
FIG. 20 Global oligonucleotide synthesis market, for equipment/synthesizer, 2018 - 2030 (USD Million)
FIG. 21 Global oligonucleotide synthesis market, for reagents, 2018 - 2030 (USD Million)
FIG. 22 Global oligonucleotide synthesis market, for services, 2018 - 2030 (USD Million)
FIG. 23 Global oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 24 Global 25 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 25 Global 50 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 26 Global 200 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 27 Global 1000 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 28 Global 10,000 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 29 Global purification market, 2018 - 2030 (USD Million)
FIG. 30 Global modification market, 2018 - 2030 (USD Million)
FIG. 31 Global oligonucleotide synthesis market: Application movement analysis
FIG. 32 Global oligonucleotide synthesis market, for PCR primers, 2018 - 2030 (USD Million)
FIG. 33 Global oligonucleotide synthesis market, for PCR assays and panels, 2018 - 2030 (USD Million)
FIG. 34 Global oligonucleotide synthesis market, for sequencing, 2018 - 2030 (USD Million)
FIG. 35 Global oligonucleotide synthesis market, for DNA Microarrays, 2018 - 2030 (USD Million)
FIG. 36 Global oligonucleotide synthesis market, for Fluorescence In Situ Hybridization (FISH), 2018 - 2030 (USD Million)
FIG. 37 Global oligonucleotide synthesis market, for antisense oligonucleotides, 2018 - 2030 (USD Million)
FIG. 38 Global oligonucleotide synthesis market, for other applications, 2018 - 2030 (USD Million)
FIG. 39 Global oligonucleotide synthesis market: End-user movement analysis
FIG. 40 Global oligonucleotide synthesis market, for academic and research institutes, 2018 - 2030 (USD Million)
FIG. 41 Global oligonucleotide synthesis market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
FIG. 42 Global oligonucleotide synthesis market, for diagnostic laboratories, 2018 - 2030 (USD Million)
FIG. 43 Regional marketplace: Key takeaways
FIG. 44 Regional outlook, 2022 & 2030
FIG. 45 Global oligonucleotide synthesis market: Region movement analysis
FIG. 46 North America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 47 U.S. oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 48 Canada oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 49 Europe oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 50 Germany oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 51 UK oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 52 France oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 53 Italy oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 54 Spain oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 55 Denmark oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 56 Sweden oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 57 Norway oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 58 Asia Pacific oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 59 Japan oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 60 China oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 61 India oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 62 Australia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 63 South Korea oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 64 Thailand oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 65 Latin America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 66 Brazil oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 67 Mexico oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 68 Argentina oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 69 Middle East and Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 70 South Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 71 Saudi Arabia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 72 UAE oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 73 Kuwait oligonucleotide synthesis market, 2018 - 2030 (USD Million)